---
title: "Endospan announces positive 30-day outcomes from TRIOMPHE IDE study"
date: "2025-05-12T09:31:54.000Z"
publishedDate: "12 mai 2025"
summary: "Endospan recently announced the presentation of 30-day results from the statistical dissection primary arm of the TRIOMPHE investigational device exemption (IDE) clinical study. The data were presented during the late-breaking trial session at the American Association for Thoracic Surgery (AATS) annual meeting (2–5 May, Seattle, USA)."
importance: ""
sourceUrl: "https://vascularnews.com/endospan-announces-positive-30-day-outcomes-from-triomphe-ide-study/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-05-12-endospan-announces-positive-30-day-outcomes-from-triomphe-ide-study"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2019/09/Nexus-stent-graft-system-web.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/endospan-announces-positive-30-day-outcomes-from-triomphe-ide-study/"
---

![Endospan announces positive 30-day outcomes from TRIOMPHE IDE study](https://vascularnews.com/wp-content/uploads/sites/7/2019/09/Nexus-stent-graft-system-web.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/endospan-announces-positive-30-day-outcomes-from-triomphe-ide-study/*

## L’essentiel

Endospan recently announced the presentation of 30-day results from the statistical dissection primary arm of the TRIOMPHE investigational device exemption (IDE) clinical study. The data were presented during the late-breaking trial session at the American Association for Thoracic Surgery (AATS) annual meeting (2–5 May, Seattle, USA).

## Lien source

https://vascularnews.com/endospan-announces-positive-30-day-outcomes-from-triomphe-ide-study/
